M. J. Biopharm Private Limited Insulin Export Data — India (DGFT 2022–2026)

Name: M. J. Biopharm Private Limited Insulin Export Records India — #2 Exporter, 303 Shipments, $15.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Insulin

India Pharmaceutical Trade Intelligence

$76.0M188 Suppliers111 CountriesHS 30043110

ExportsIndia → THAILAND28.6%India → MEXICO19.2%

ImportsDENMARK → India$358.7B BRAZIL → India$149.3B

#1 Supplier: WOCKHARDT LIMITED

M. J. Biopharm Private Limited — Insulin Exporter #2 | $18.9M Trade Value | TransData Nexus | TransData Nexus

M. J. Biopharm Private Limited — Insulin Exporter Profile

Indian Pharmaceutical Exporter · #2 for Insulin · $18.9M export value · DGFT Verified

M. J. Biopharm Private Limited is the #2 Indian exporter of Insulin with $18.9M in export value and 303 verified shipments. M. J. Biopharm Private Limited holds a 19.9% market share in Insulin exports across 23 countries. The company exports 6 pharmaceutical products worth $22.4M across 4 therapeutic categories.

M. J. Biopharm Private Limited — Insulin Export Profile: Buyers & Destinations

M. J. Biopharm Private Limited Insulin export treemap — buyers and destination countries | TransData Nexus

Where Does M. J. Biopharm Private Limited Export Insulin?

Country	Value	Shipments	Share
THAILAND	$3.6M	109	43.8%
DOMINICAN REPULIC	$911.5K	24	11.2%
GUYANA	$802.4K	25	9.9%
DOMINICAN REPUBLIC	$439.9K	13	5.4%
ETHIOPIA

Who Are the Top Buyers of Insulin from M. J. Biopharm Private Limited?

Buyer	Country	Value	Orders
BJC HEALTHCARE COMPANY LIMITED	THAILAND	$3.0M	95
DIABETIKA SRL	DOMINICAN REPULIC	$1.1M	31
NEW GPC INC	GUYANA	$619.1K	17
COMMERCIAL BANK OF ETHIOPIA	ETHIOPIA	$388.0K	9
INTERNATIONAL DRUG COMPANY LIMITED	ZAMBIA	$353.0K	16
BJC HEALTHCARE CO., LTD.	THAILAND	$300.5K	7
SIDPHARMA	DOMINICAN REPULIC	$215.2K	6
NATIONAL HEALTH FUND	JAMAICA	$177.8K	6
ZUMA PHARMA LLC	UZBEKISTAN	$175.7K	6
M/S. BJC HEALTHCARE COMPANY LIMITED	THAILAND	$174.2K	4

M. J. Biopharm Private Limited supplies Insulin to 44 buyers globally. The largest buyer is BJC HEALTHCARE COMPANY LIMITED (THAILAND), followed by DIABETIKA SRL (DOMINICAN REPULIC) and NEW GPC INC (GUYANA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Insulin Formulations Does M. J. Biopharm Private Limited Export?

Product Description / Formulation	Value	Shipments
BIOSULIN 3070 INSULIN INJ.BIPHASIC ISOP	$672.5K	17
BIOSULIN 30:70 INSULIN INJECTION BIPHASI	$516.6K	13
BIOSULIN N INSULIN INJECTION ISOPHANE PH	$446.9K	16
BIOSULIN N INSULIN INJ. ISOPHANE PH.EUR.	$142.3K	3
BIOSULIN 3070 INSULIN INJ.BIPHASIC ISOPHANE PH.EUR.100 IU/ML3ML(HUMAN INSULININJ.100 IU/ML3ML CARTRIDGE)30832 PACKSNOS	$141.5K	3
BIOSULIN L (INSULIN ZINC INJECTABLE SUSP	$140.6K	4
BIOSULIN 30/70 INSULIN INJECTION BIPHASIC ISOPHANE PH.EUR.100 IU/ML10 ML (HUMAN INSULIN INJECTION 100 IU/ML10 ML VIALVLS	$138.7K	3
BIOSULIN N INSULIN INJECTION ISOPHANE PH.EUR.100 IU/ML10 ML (HUMAN INSULIN INJECTION 100 IU/ML10 ML VIALS) 80000PACKSVLS	$127.1K	3
BIOSULIN 3070 (INSULIN INJ.BIPHASIC ISO	$125.9K	3
BIOSULIN 30:70 INSULIN INJ.BIPHASIC ISOPHANE PH.EUR.100 IU/ML,3ML(HUMAN INSULIN INJ.100 IU/ML, 3ML CARTRIDGE)	$120.8K	3

M. J. Biopharm Private Limited exports 200 distinct Insulin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BIOSULIN 3070 INSULIN INJ.BIPHASIC ISOP with 17 shipments worth $672.5K.

How Does M. J. Biopharm Private Limited Compare to Nearest Insulin Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	WOCKHARDT LIMITED	$22.7M	454	25	$50.0K
2	M. J. BIOPHARM PRIVATE LIMITED ★	$15.2M	303	23	$50.0K
4	GLAND PHARMA LTD	$4.0M	81	4	$50.0K
3	M J BIOPHARM PRIVATE LIMITED ★	$3.8M	75	15	$50.0K

M. J. Biopharm Private Limited ranks #2 among 188 Indian Insulin exporters. Average shipment value of $50.0K compared to the market average of $278.5K. The closest competitors by value are WOCKHARDT LIMITED and GLAND PHARMA LTD.

Which Indian Ports Ship Insulin Exports?

Port	Shipments	% Share
SAHAR AIR	704	27.8%
SAHAR AIR CARGO ACC (INBOM4)	646	25.5%
Bombay Air	177	7.0%
Bombay Air Cargo	123	4.9%
NHAVA SHEVA SEA (INNSA1)	108	4.3%
DELHI AIR	76	3.0%
BANGALORE ACC (INBLR4)	69	2.7%
JNPT	68	2.7%

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Insulin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like M. J. Biopharm. Escalating tensions in the Middle East, particularly the Israel-Iran conflict, have disrupted key shipping routes through the Red Sea and the Suez Canal. Major carriers have suspended or rerouted shipments, leading to increased transit times and freight costs. This situation poses significant logistical hurdles for time-sensitive pharmaceutical exports. (livemint.com)

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the U.S. has also implemented policies favoring domestic manufacturing, such as the "Buy American" initiative, which could impact Indian companies' access to this lucrative market. (walterhealthcare.co.in)

In the European Union, stringent regulations like the Falsified Medicines Directive necessitate rigorous compliance from exporters. Indian companies must navigate these complex requirements to maintain market access, emphasizing the need for robust quality assurance systems. (ipa-india.org)

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Indian companies have faced challenges, including increased compliance costs and potential reductions in export volumes due to evolving regulations. (transdatanexus.com)

For M. J. Biopharm, maintaining adherence to these standards is crucial to sustain and expand its export markets. Investments in quality control, staff training, and infrastructure are essential to meet the evolving requirements and to build trust with international partners and regulatory bodies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Insulin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: M. J. Biopharm Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 303 individual customs records matching M. J. Biopharm Private Limited exporting Insulin, covering 200 formulations to 24 countries via 44 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 111+ countries, 384+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Insulin

Insulin

M. J. Biopharm Private Limited — Insulin Exporter Profile

M. J. Biopharm Private Limited — Insulin Export Profile: Buyers & Destinations

Where Does M. J. Biopharm Private Limited Export Insulin?

Who Are the Top Buyers of Insulin from M. J. Biopharm Private Limited?

What Is India's Total Insulin Export Value and How Much Does M. J. Biopharm Private Limited Contribute?

What Is the Average Shipment Value for M. J. Biopharm Private Limited's Insulin Exports?

How Does M. J. Biopharm Private Limited Compare to Other Indian Insulin Exporters?

What Insulin Formulations Does M. J. Biopharm Private Limited Export?

How Does M. J. Biopharm Private Limited Compare to Nearest Insulin Exporters?

Which Indian Ports Ship Insulin Exports?

Insulin — Export Intelligence Video

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Insulin Exports

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

About M. J. Biopharm Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Insulin Export Data from M. J. Biopharm Private Limited

Insulin Stats

Company Overview

Top Products by M. J. Biopharm Private Limited

Related Analysis

Need Detailed Export Data?

Data Source